Picture of Csl logo

CSL Csl News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: CSL Expects FY26 Revenue $15.2 Bln, NPATA $3.1 Bln At Constant Currency

May 11 (Reuters) - CSL Ltd CSL.AX:

INTERIM CEO 90 DAY REVIEW AND FINANCIAL UPDATE

EXPECTS $300 MILLION FY26 REVENUE IMPACT FROM U.S. IMMUNOGLOBULIN CHANNEL INVENTORY NORMALISATION

EXPECTS $200 MILLION FY26 REVENUE IMPACT FROM CHINA ALBUMIN MARKET VALUE DECLINE

EXPECTS FY26 REVENUE OF $15.2 BILLION AND NPATA OF $3.1 BILLION CONSTANT CURRENCY

EXPECTS $150 MILLION FY26 REVENUE IMPACT FROM MIDDLE EAST CONFLICT, HEMGENIX, AND IRON COMPETITION

EXPECTS $5 BILLION NON-CASH PRE-TAX IMPAIRMENTS ACROSS FY26 AND FY27

Further company coverage: CSL.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Csl

See all news